Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar Reddragyn (68.13) Submitted: 1/24/2011 5:04:28 AM : Outperform Start Price: $37.97 GILD Score: +30.00

MF/M

Report this Post 1 Comment
Member Avatar Reddragyn (68.13) Submitted: 4/12/2012 2:02:51 PM
Recs: 0

+5/1 Sort

Report this Post

Featured Broker Partners


Advertisement